dr. blackwell discusses tucatinib in her2 breast cancer
Published 6 years ago • 719 plays • Length 2:36Download video MP4
Download video MP3
Similar videos
-
1:43
dr. blackwell discusses the her2climb study in her2 breast cancer
-
1:00
dr. blackwell discusses margetuximab for her2 breast cancer
-
1:39
dr. blackwell on treatment landscape of her2 breast cancer
-
1:44
dr. blackwell on neratinib in her2 breast cancer
-
0:51
dr. hamilton discusses tucatinib in her2 breast cancer
-
3:08
the benefits of tucatinib in her2 breast cancer
-
3:15
a close look at tucatinib in her breast cancer
-
1:15
dr. blackwell on the impact of the cleopatra and marianne studies in her2 breast cancer
-
0:48
dr. czerniecki on the benefit of tucatinib in her2 breast cancer and brain metastases
-
1:13
dr. hamilton on the efficacy of trastuzumab deruxtecan in her2-low breast cancer
-
1:40
dr. tolaney discusses neratinib in her2 breast cancer
-
5:14
her2 mbc: systemic therapies and her2climb-02 trial
-
2:15
dr. hamilton on the promise of tucatinib in her2 breast cancer brain metastases
-
1:10
dr. hamilton on the fda approval of tucatinib in her2 breast cancer
-
6:06
combining anti-her2 agents with immunotherapy for her2 mbc
-
3:44
her2 breast cancer: brain metastasis prevalence & later-line therapy
-
0:57
dr. mittendorf on the impact of pertuzumab in her2 breast cancer
-
1:54
dr. khong on endocrine combinations in er /her2- breast cancer
-
0:50
dr. ellis on immunotherapy in her2 breast cancer